- List
- By Topic
- On Map
- Search Details
Study record managers: refer to the Data Element Definitions if submitting registration or results information.
x
1 | NCT01884740 | Recruiting | Intraarterial Infusion Of Erbitux and Bevacizumab For Relapsed/Refractory Intracranial Glioma In Patients Under 22 |
|
|
Interventional | Phase 1 Phase 2 |
|
Other |
|
|
30 | All | 1 Year to 21 Years (Child, Adult) | NCT01884740 | 1202012214 | June 2013 | January 2019 | January 2019 | June 24, 2013 | January 30, 2018 |
|